Coloplast A/S
CSE:COLO B
Net Margin
Coloplast A/S
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| DK |
|
Coloplast A/S
CSE:COLO B
|
137.8B DKK |
16%
|
|
| CH |
|
Alcon AG
SIX:ALC
|
34.7B CHF |
11%
|
|
| JP |
|
Hoya Corp
TSE:7741
|
5.8T JPY |
23%
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.2B USD |
10%
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.8B GBP |
8%
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
5.5B CHF |
12%
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
45.6B CNY |
40%
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
5.5B USD |
9%
|
|
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.5B USD |
17%
|
|
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
7T KRW |
-253%
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
621.9B JPY |
9%
|
Coloplast A/S
Glance View
Coloplast A/S, headquartered in Humlebæk, Denmark, has a storied history that dates back to 1954 when a nurse, Elise Sørensen, identified a crucial need in the healthcare sector. Her sister had undergone ostomy surgery, and the lack of appropriate post-operative care products inspired Sørensen to design the world’s first adhesive ostomy bag. This innovation laid the groundwork for Coloplast's trajectory in the healthcare industry. Today, the company has expanded its focus to include ostomy care, continence care, wound and skin care, and interventional urology. With a commitment to improving patients' quality of life, Coloplast has become a leader in designing and manufacturing products that not only highlight practicality but also embody comfort and discretion. Coloplast generates revenue through a business model that emphasizes product innovation and direct engagement with healthcare providers and patients. The company invests significantly in research and development to improve and widen its product offerings continuously. It operates globally, distributing its products directly and via partnerships with hospitals, clinics, and healthcare professionals. By maintaining an attentive approach to user experience and incorporating customer feedback into its development processes, Coloplast ensures its portfolio aligns with the actual needs of its users. This user-centered strategy not only enhances customer loyalty but also fortifies the company’s market position, driving its financial success.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Coloplast A/S's most recent financial statements, the company has Net Margin of 16.4%.
You don't have any saved screeners yet